DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0018799 | Heart Diseases | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0013421 | Dystonia | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C4048158 | Convulsions | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C1449563 | Cardiomyopathy, Familial Idiopathic | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0001125 | Acidosis, Lactic | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0025202 | melanoma | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0751285 | Maple Syrup Urine Disease, Thiamine Responsive | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C1855371 | MAPLE SYRUP URINE DISEASE, TYPE II | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C1621958 | Glioblastoma Multiforme | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0278878 | Adult Glioblastoma | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0678222 | Breast Carcinoma | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0038436 | Post-Traumatic Stress Disorder | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0008312 | Primary biliary cirrhosis | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0007124 | Noninfiltrating Intraductal Carcinoma | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0006826 | Malignant Neoplasms | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0036857 | Severe intellectual disability | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0006114 | Cerebral Edema | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0030305 | Pancreatitis | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0023892 | Biliary cirrhosis | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0013146 | Drug abuse | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0241910 | Autoimmune Chronic Hepatitis | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C3714756 | Intellectual Disability | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0017636 | Glioblastoma | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C0017638 | Glioma | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024